World's Best Scientists 2026 revealed!
Bob Löwenberg

Bob Löwenberg

Award Badge
Medicine
Netherlands
2023

D-Index & Metrics

Medicine

D-Index
140
Citations
92374
World Ranking
1665
National Ranking
57

Research.com Recognitions

  • 2023 - Research.com Medicine in Netherlands Leader Award
  • 1996 - Royal Netherlands Academy of Arts and Sciences

Overview

Bob Löwenberg is affiliated with Erasmus MC in the Netherlands and has a research focus heavily oriented toward hematology and molecular biology within the broader field of medicine. Their scholarly output includes a significant body of work centered on hematologic malignancies, particularly acute myeloid leukemia (AML).

Their publication record includes contributions to the understanding and management of AML and related disorders. Notable recent papers include:

  • Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN (2022, Blood)
  • International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data (2022, Blood)
  • Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia (2020, Blood)
  • Towards precision medicine for AML (2021, Nature Reviews Clinical Oncology)
  • Molecular characterization of mutant TP53 acute myeloid leukemia and high-risk myelodysplastic syndrome (2022, Blood)

Their frequent coauthors reflect a collaborative research approach with notable colleagues including:

  • Peter J.M. Valk
  • Gert J. Ossenkoppele
  • Markus G. Manz
  • Dimitri Breems
  • Jacqueline Cloos

Löwenberg's work has been published predominantly in journals specializing in hematologic research and oncology, with frequent venues such as:

  • Blood
  • Blood Advances
  • Leukemia
  • Clinical Lymphoma Myeloma & Leukemia
  • HemaSphere

Their main fields of study include medicine and biochemistry, genetics and molecular biology, with substantial contributions to subfields like hematology, molecular biology, genetics, immunology, and occupational health.

Specific research topics addressed by Löwenberg span:

  • Acute Myeloid Leukemia Research
  • Hematopoietic Stem Cell Transplantation
  • Acute Lymphoblastic Leukemia research
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Histone Deacetylase Inhibitors Research
  • Retinoids in leukemia and cellular processes
  • Protein Degradation and Inhibitors

Throughout their career, Löwenberg received recognition such as election to the Royal Netherlands Academy of Arts and Sciences in 1996.

Best Publications

  • Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

    Hartmut Döhner;Elihu Estey;David Grimwade;Sergio Amadori

  • Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet.

    Hartmut Dohner;Elihu H. Estey;Sergio Amadori;Frederick R. Appelbaum

  • Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

    Bruce D. Cheson;John M. Bennett;Kenneth J. Kopecky;Thomas Büchner

  • Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation.

    Maria E. Figueroa;Omar Abdel-Wahab;Chao Lu;Patrick S. Ward

  • Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia

    Bruce D. Cheson;Peter L. Greenberg;John M. Bennett;Bob Lowenberg

  • Prognostically useful gene-expression profiles in acute myeloid leukemia.

    Peter J.M. Valk;Roel G.W. Verhaak;M. Antoinette Beijen;Claudia A.J. Erpelinck

  • Efficacy and Safety of Gemtuzumab Ozogamicin in Patients With CD33-Positive Acute Myeloid Leukemia in First Relapse

    Eric L. Sievers;Richard A. Larson;Edward A. Stadtmauer;Elihu Estey

  • Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

    Miguel A. Sanz;David Grimwade;Martin S. Tallman;Bob Lowenberg

  • Therapeutic Advances in Acute Myeloid Leukemia

    Alan Kenneth Burnett;M. Wetzler;B. Lowenberg

  • DNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid Leukemia

    Maria E. Figueroa;Sanne Lugthart;Yushan Li;Claudia Erpelinck-Verschueren

  • High-dose daunorubicin in older patients with acute myeloid leukemia.

    Bob Löwenberg;Gert J. Ossenkoppele;Wim van Putten;Harry C. Schouten

  • Report of an international working group to standardize response criteria for myelodysplastic syndromes

    B. D. Cheson;J. M. Bennett;Hagop M Kantarjian;A. Pinto

  • Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): Association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance

    Roel G. W. Verhaak;Chantal S. Goudswaard;Wim van Putten;Maarten A. Bijl

  • A 17-gene stemness score for rapid determination of risk in acute leukaemia

    Stanley W. K. Ng;Amanda Mitchell;James A. Kennedy;James A. Kennedy;James A. Kennedy;Weihsu C. Chen

  • Monosomal Karyotype in Acute Myeloid Leukemia: A Better Indicator of Poor Prognosis Than a Complex Karyotype

    Dimitri A. Breems;Wim L. J. Van Putten;Georgine E. De Greef;Shama L. Van Zelderen-Bhola

  • Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome

    Bas J. Wouters;Bob Löwenberg;Claudia A. J. Erpelinck-Verschueren;Wim L. J. van Putten

  • Molecular Minimal Residual Disease in Acute Myeloid Leukemia

    Mojca Jongen-Lavrencic;Tim Grob;Diana Hanekamp;François G Kavelaars

  • A Single Oncogenic Enhancer Rearrangement Causes Concomitant EVI1 and GATA2 Deregulation in Leukemia

    Stefan Gröschel;Stefan Gröschel;Mathijs A Sanders;Remco Hoogenboezem;Elzo de Wit

  • Prognostic Index for Adult Patients With Acute Myeloid Leukemia in First Relapse

    Dimitri A. Breems;Wim L.J. Van Putten;Peter C. Huijgens;Gert J. Ossenkoppele

  • Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?

    Jan J. Cornelissen;Wim L. J. van Putten;Leo F. Verdonck;Matthias Theobald

Frequent Co-Authors

Peter J. M. Valk
Peter J. M. Valk Erasmus University Rotterdam
Ruud Delwel
Ruud Delwel Erasmus MC
Jan J. Cornelissen
Jan J. Cornelissen Erasmus University Rotterdam
Pieter Sonneveld
Pieter Sonneveld Erasmus University Rotterdam
Ivo P. Touw
Ivo P. Touw Erasmus University Rotterdam
Miguel A. Sanz
Miguel A. Sanz University of Valencia
Edo Vellenga
Edo Vellenga University Medical Center Groningen
Gert J. Ossenkoppele
Gert J. Ossenkoppele University of Amsterdam
Hartmut Döhner
Hartmut Döhner University of Ulm

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine often involves exploring a range of educational and professional pathways beyond traditional medical schools. Many students choose alternative or supplementary degrees in healthcare, such as nursing, that offer flexibility and a variety of specializations.

Today, online programs are making advanced degrees more accessible and affordable. For those seeking the highest academic credentials, there are online phd programs nursing that combine research, leadership, and teaching roles in healthcare. Registered nurses looking to further their qualifications can benefit from the cheapest rn to bsn program online, expanding their knowledge while continuing to work.

Those without a nursing background also have opportunities through direct msn programs online, which are designed for non-nurses aiming to enter the field and gain advanced practice skills quickly. Furthermore, aspiring nurses can begin their careers with direct entry nursing programs, which tend to have more accessible admission requirements.

These online degree options offer flexible, cost-effective ways to build a rewarding career in healthcare—whether you are just starting out or seeking advanced roles.

Best Scientists Citing Bob Löwenberg

Trending Scientists